% Expired Patents = 50.0

Forward Citations = 165

Loading Chart...

6 inventors (with patents filed for the assignee):

Gyula Hadlaczky (2 out of 8 patents)

Gary deJong (2 out of 2 patents)

Sandra Louise Vanderbyl (2 out of 2 patents)

4. Aladar A Szalay (2 out of 44 patents)

5. Volker Oberle (1 out of 1 patent)

6. Dirk Hoekstra (1 out of 3 patents)

4 patents: Sort by Forward Citations

1. 7294511 - Methods for delivering nucleic acid molecules into cells and assessment thereof (2007-11-13),

2. 6936469 - Methods for delivering nucleic acid molecules into cells and assessment thereof (2005-08-30),

3. 6077697 - Artificial chromosomes, uses thereof and methods for preparing (2000-06-20),

4. 6025155 - Artificial chromosomes, uses thereof and methods for preparing (2000-02-15),

Company Overview

Chromos Molecular Systems, Inc. is a biotechnology company specializing in developing novel drug delivery technologies. With a focus on designing advanced drug delivery systems, Chromos Molecular Systems aims to improve the efficacy and safety of pharmaceuticals. Their innovative solutions have the potential to revolutionize the healthcare industry by providing more targeted and efficient drug delivery methods.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#221 in Vancouver

#3,464 in Canada

Vancouver, Canada

Chromos Molecular Systems, Inc.

Forward Citations = 165

6 inventors:

Gyula Hadlaczky (2 out of 8 patents)

Gary deJong (2 out of 2 patents)

Sandra Louise Vanderbyl (2 out of 2 patents)

4. Aladar A Szalay (2 out of 44 patents)

5. Volker Oberle (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chromos Molecular Systems, Inc.. Retrieved from https://idiyas.com/company/chromos-molecular-systems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]